COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

30,724 Articles (22,502 medRxiv, 8,222 bioRxiv)

Most recent first Previous |  Page 200: Articles 1991-2000  | Next

Evaluating the impacts of tiered restrictions introduced in England in December 2020 on covid-19 hospitalisations: a synthetic control study.
Zhang, X., Hungerford, D., Green, M., Garcia-Finana, M., Buchan, I., Barr, B.
10.1101/2024.02.28.24303487 — Posted: 2024-02-29
COVID-19 vaccine uptake and associated risk factors among first antenatal care attendees in Zambia, 2021-2022: a repeated cross-sectional study
Tembo, T., Heilmann, E., Somwe, P., Bosomprah, S., Kalenga, K., Moyo, N., Kabamba, B., Seffren, V., Fwoloshi, S., Rutagwera, M.-R., Musunse, M., Mwiinga, L., Gutman, J. R., Hines, J. Z., Sikazwe, I.
10.1101/2024.02.27.24303454 — Posted: 2024-02-29
Implementation and Adherence to Regular Asymptomatic Testing in a COVID-19 Vaccine Trial
Williams, L. R., Emary, K. R., Phillips, D. J., Hay, J., Larwood, J. P., Ramasamy, M. N., Pollard, A. J., Grassly, N. C., Voysey, M.
10.1101/2024.02.28.24303505 — Posted: 2024-02-29
A structured course of disease dataset with contact tracing information in Taiwan for COVID-19 modelling
Wu, Y.-H., Nordling, T. E. M.
10.1101/2024.02.28.24303518 — Posted: 2024-02-29
Neutrophil-to-Lymphocyte Ratio as a Prognostic Indicator in COVID-19: Evidence from a Northern Tanzanian Cohort
Kyala, N. J., Mboya, I., Shao, E., Sakita, F., Kilonzo, K. G., Shirima, L., Sadiq, A., Mkwizu, E., Chamba, N., Marandu, A., Muhali, S., Raza, F., Ndale, E., Bayo, D., Mujuni, D., Lyamuya, F.
10.1101/2024.02.28.24303516 — Posted: 2024-02-29
Virus-derived Synthetic Riboswitches for Real-time Coronaviruses Sensing in Live Cells
Zeng, L., Qi, L. S.
10.1101/2024.02.27.582433 — Posted: 2024-02-29
Discovery of anti-SARS-CoV-2 S2 protein antibody CV804 with broad-spectrum reactivity with various beta coronaviruses and analysis of its pharmacological properties in vitro and in vivo
Tsugawa, Y., Furukawa, K., Ise, T., Takayama, M., Ota, T., Kuroda, T., Shano, S., Hashimoto, T., Konishi, H., Ishihara, T., Sato, M., Kamada, H., Fukao, K., Shishido, T., Takahashi, T., Nagata, S.
10.1101/2024.02.28.582480 — Posted: 2024-02-29
Protective effect and molecular mechanisms of human non-neutralizing cross-reactive spike antibodies elicited by SARS-CoV-2 mRNA vaccination
Clark, J., Hoxie, I., Adelsberg, D., Sapse, I., Andreata-Santos, R., Yong, J., Amanat, F., Tcheou, J., Raskin, A., Singh, G., Gonzalez-Dominguez, I., Edgar, J., Bournazos, S., Sun, W., Carreno, J. M., Simon, V., Ellebedy, A., Krammer, F.
10.1101/2024.02.28.582613 — Posted: 2024-02-29
Peptide Mold: A Novel Strategy for Mapping Potential Binding Sites in Protein Targets
Bagwe, P. B., Jagtap, Y., Ghegade, V., Machhar, J. S., Martis, E., Joshi, S. V., Kharkar, P. S.
10.1101/2024.02.28.582665 — Posted: 2024-02-29
Machine Learning for COVID-19 Patient Management: Predictive Analytics and Decision Support
El Hadi, C., El Hadi, R., Riachy, M., Maalouly, G., Sleilaty, G.
10.1101/2024.02.26.24303208 — Posted: 2024-02-28

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).